Larimar Therapeutics Inc

NASDAQ:LRMR   11:43:11 AM EDT
13.04
+0.30 (+2.36%)
Earnings Announcements

Larimar Therapeutics Reports Second Quarter 2021 Operating And Financial Results

Published: 08/12/2021 11:46 GMT
Larimar Therapeutics Inc (LRMR) - Larimar Therapeutics Reports Second Quarter 2021 Operating and Financial Results.
Q2 Loss per Share $0.79.
Q2 Earnings per Share Estimate $-0.75 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.64

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.58

More details on our Analysts Page.